IFB-088 (icerguastat) was safe and significantly slowed disease progression in certain people with ALS in a Phase 2 clinical trial.

Largo Inc. ("Largo" or the "Company") (TSX: LGO) (NASDAQ: LGO) today announces annual production of 9,264 tonnes (20.4 million lbs¹) of vanadium pentoxide ("V2O5") equivalent ...

Federal criminal charges have been filed against two former DWI officers in one of the largest corruption cases to hit local law enforcement. Honorio Alba Jr. and Joshua Montaño appeared as defendants ...

Enfinity Global Inc., a leader in renewable energy, today announced the expansion of its battery energy storage systems (BESS) portfolio with two new projects ...

Quimbaya Gold Inc. is pleased to announce the results of a rock sampling program conducted on the Tahami North project in Segovia, Colombia. These results include rock samples grading up to 5.86 g/t ...

Yes, amyotrophic lateral sclerosis (ALS) can cause quadriplegia. ALS is a condition that causes gradual loss of muscle function. It can appear in various forms, including subtypes such as bulbar ...

Flights from one of the world’s largest airport projects may be grounded within 30 years due to the risk of sinking land and rising sea levels. You can update your preferences or unsubscribe at any ...

Global growth is projected at 3.3 percent both in 2025 and 2026, below the historical (2000–19) average of 3.7 percent. The forecast for 2025 is broadly unchanged from that in the October 2024 World ...

“This Orphan Drug Designation from the USFDA underlines the urgent need to develop Usnoflast to address Amyotrophic Lateral Sclerosis (ALS), which is a fatal neurodegenerative disease," said Zydus' ...

Ricardo Godoi, 45, went into cardiac arrest at a private hospital during the tattoo session - with doctors unable to revive him. The Brazilian influencer employed a tattoo studio who said they ...

Brazilian influencer Ricardo Godoi died while he was under anesthesia for a tattoo procedure. He was 45. “Today we say goodbye to Ricardo Godoi, an incredible person who left his mark on the ...

In phase 2, pridopidine showed encouraging results for the potential treatment of ALS with a good safety profile. Based on these findings, Prilenia is planning a single, global, pivotal phase 3 ...